Latest VIDA Diagnostics Stories

VIENNA, Sept. 3, 2012 /PRNewswire/ -- VIDA Diagnostics, a leading developer of quantitative imaging analysis software for the diagnosis and treatment planning of major pulmonary disease, announced today the release and commercial availability of Apollo® 1.2, here at the European Respiratory Society (ERS) meeting in Vienna, Austria. Apollo 1.2 showcases improved workflow and dataflow functionality streamlining VIDA's software as a service model, new interactive procedure planning...

CORALVILLE, Iowa, Sept. 19, 2011 /PRNewswire/ -- VIDA Diagnostics, a leading developer of quantitative pulmonary imaging software, announced today that the company has achieved International Organization for Standardization (ISO 13485) certification and CE certification for its flagship product, Apollo®. The CE certification permits VIDA to sell Apollo for clinical use in the European Economic Area (EEA) and Switzerland. Apollo currently has FDA 510(k) approval for clinical use in the...

DENVER, May 16, 2011 /PRNewswire/ -- VIDA Diagnostics, a leading developer of quantitative pulmonary imaging software, announced today the launch of its new Apollo(TM) Software for the evaluation of pulmonary disease including chronic obstructive pulmonary disease (COPD), asthma, and lung cancer, here at the 2011 International Conference of the American Thoracic Society (ATS). VIDA also announced that Apollo has been installed at leading pulmonary centers for validation and clinical use,...

IOWA CITY, Iowa and ST. LOUIS, Nov. 29 /PRNewswire/ -- VIDA Diagnostics, a leading developer of quantitative imaging software for the advanced analysis of pulmonary diseases, and Veran Medical Technologies, a leader in minimally invasive delivery of interventional oncology therapies, announced the companies have signed a definitive agreement covering joint development and distribution of an endobronchial lung navigation and biopsy system. "Veran's innovative instrumentation and automatic...